A Phase II Trial of Neoadjuvant Chemotherapy with Genexol® (Paclitaxel) and Epirubicin for Locally Advanced Breast Cancer.

Lee, Jinsun; Kim, Jeryong; Chang, Eilsung; Choi, Woonjung; Lee, Kwangman; Yoon, Hyunjo; Jung, Sunghoo; Park, Minho; Yoon, Junghan; Kim, Sungyong

Lee, Jinsun; Kim, Jeryong; Chang, Eilsung; Choi, Woonjung; Lee, Kwangman; Yoon, Hyunjo; Jung, Sunghoo; Park, Minho; Yoon, Junghan; Kim, Sungyong.

Afiliación

Lee J; Department of Surgery, Chungnam National University, Daejoen, Korea.
Kim J; Department of Surgery, Chungnam National University, Daejoen, Korea.
Chang E; Department of Surgery, Chungnam National University, Daejoen, Korea.
Choi W; Department of Surgery, Wonkwang University School of Medicine, Iksan, Korea.
Lee K; Department of Surgery, Wonkwang University School of Medicine, Iksan, Korea.
Yoon H; Department of Surgery, Chonbuk National University Medical School, Jeonju, Korea.
Jung S; Department of Surgery, Chonbuk National University Medical School, Jeonju, Korea.
Park M; Department of Surgery, Chonnam National University Hwasun Hospital, Hwasun, Korea.
Yoon J; Department of Surgery, Chonnam National University Hwasun Hospital, Hwasun, Korea.
Kim S; Department of Surgery, Soonchunhyang University Cheonan Hospital, Cheonan, Korea.

J Breast Cancer ; 17(4): 344-9, 2014 Dec.

Article en En | MEDLINE | ID: mdl-25548582

Palabras clave

Breast neoplasms; Epirubicin; Neoadjuvant therapy; Paclitaxel

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: J Breast Cancer Año: 2014 Tipo del documento: Article